Global Biotech Revolution & are partnering for GapSummit 2016

Although summer may be over, we’ve got some hot news to announce! We are partnering with Global Biotech Revolution and it’s flagship event, GapSummit 2016.

Global Biotech Revolution (GBR) is a not-for-profit organisation that connects biotech think-tanks, industrial leaders and research pioneers to the young bio-leaders of tomorrow. GBR do this by creating a network of young and current bio-leaders who grow together by supporting each other’s ideas and knowledge. They engage key stakeholders through both physical and online platforms that initiate and build future global conversations and collaborations. All of this is achieved through their event, GapSummit.

GapSummit is the world’s first inter-generational inter-cultural leadership summit in biotech. The next GapSummit will be held  between 4th to 6th April 2016 in Cambridge, UK, one of the leading biotech clusters of the world, at the University of Cambridge. 100 young ‘bio-leaders of tomorrow’ will be selected from across the world to participate and will discuss the current global bio-economy, grand challenges of biotech can solve by 2050 and explore the UK biotech industry. Applications for this must-go event opened on the 19/09/2015 and will close on 29/11/2015. Are you interested? Click here to apply.


We are very happy to partner with both an exceptional organisation and event like GBR and its GapSummit. We believe the present ideas in biotech will be implemented effectively by the bio-leaders of tomorrow. We also believe Europe has an important role to play in the future of Biotechnology worldwide and we share this common vision. Last but not least, we want to provide these bio-leaders with the best source of biotech news and innovations from across Europe and this partnership will allow us to do so.

Everyone here at Labiotech are excited to announce this partnership and we are sure we will do extraordinary things together.

Let's Continue The Conversation

Feel free to send us comments about this article to and/or comment on that article on social media.

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.